Additional Topics in This Section
Molecular Medicine at Fox Chase
Read more »
Our research faculty
Read more »
Fox Chase Cancer Center and Lincoln University partner for cancer research and training.
Read more »
Researchers at Fox Chase investigate problems that range from understanding the fundamental mechanisms of biomolecular reactions all the way to the treatment of neoplastic diseases in the clinic.
The science is conducted with Fox Chase's commitment to research and interdisciplinary interaction. Current faculty research programs are wide-ranging and include:
Talbot Research Library
Education and Training
The Scientist names Fox Chase among the "Best Places to Work" for postdocs.
- Postdoctoral Research Program
- Graduate Student Program
- Clinical Fellowships
- Pre-Graduate Research Program
Through performance of clinical trials, Fox Chase clinical researchers convert the insights from basic and translational research into the design and evaluation of new therapeutic regimens. Fox Chase Cancer Center has developed a large, centralized, and efficient infrastructure to support clinical trial efforts. Read More »
The FCCC Extramural Research Program enables patients and physicians to participate in clinical trials in the community. These studies involve cancer patients and healthy individuals to answer specific questions about the effectiveness of new ways to prevent, detect, treat and control cancer.
The Fox Chase Cancer Center Extramural Research Program develops and supports research studies for community affiliates focusing in cancer prevention, detection and control. These research studies translate good science into better cancer medicine for everyone. Working with the community, Fox Chase Cancer Center is able to provide cancer patients and healthy individuals access to new prevention, control and treatment studies closer to home. Read More »
The SPORE in Ovarian Cancer is a National Cancer Institute-funded program for the prevention, diagnosis and treatment of ovarian cancer. Fox Chase is the only center in Pennsylvania and the first of only two facilities on the entire East Coast to receive a SPORE grant for ovarian cancer. The SPORE in Ovarian Cancer consists of six translational research projects that represent a diversity of objectives, including diagnosis, prevention, and treatment. Read More »
Begun in 2001, the American-Russian Cancer Alliance (ARCA) is a consortium of cancer research institutes led by Fox Chase for the purpose of bridging scientific research and medical education efforts between the two nations. ARCA affiliates include the University of Maryland-Greenebaum Cancer Center , N.N. Blokhin Cancer Center, and the Russian Research Centre-Kurchatov Institute, Russia's premier nuclear research center. The National Cancer Institute supports ARCA through a supplement to the Cancer Center Core Grant awarded to the Fox Chase Cancer Center.
Two main research initiatives have emerged through the consortium. The first leverages Russian expertise in the development of radioisotopes to create new diagnostic and therapeutic techniques for oncology. The second exports American population science research expertise to Russia, particularly as it relates to tobacco control research. Read More »